Pharvaris NV (PHVS)
18.43
-0.49
(-2.59%)
USD |
NASDAQ |
Sep 27, 16:00
18.43
0.00 (0.00%)
After-Hours: 18:36
Pharvaris Cash and Short Term Investments (Quarterly): 368.28M for June 30, 2024
Cash and Short Term Investments (Quarterly) Chart
Historical Cash and Short Term Investments (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2024 | 368.28M |
| March 31, 2024 | 397.77M |
| December 31, 2023 | 432.47M |
| September 30, 2023 | 167.62M |
| June 30, 2023 | 194.73M |
| March 31, 2023 | 147.41M |
| December 31, 2022 | 173.55M |
| September 30, 2022 | 194.35M |
| June 30, 2022 | 210.36M |
| Date | Value |
|---|---|
| March 31, 2022 | 217.39M |
| December 31, 2021 | 237.03M |
| September 30, 2021 | 253.55M |
| June 30, 2021 | 266.94M |
| March 31, 2021 | 279.38M |
| December 31, 2020 | 121.31M |
| September 30, 2020 | 49.25M |
| December 31, 2019 | 22.77M |
Cash and Short Term Investments Definition
Cash and Short Term investments is the sum of two balance sheet line items: cash and equivalents and short term investments in marketable securities.
Cash and Short Term Investments (Quarterly) Range, Past 5 Years
22.77M
Minimum
Dec 2019
432.47M
Maximum
Dec 2023
219.66M
Average
210.36M
Median
Jun 2022
Cash and Short Term Investments (Quarterly) Benchmarks
| uniQure NV | 524.43M |
| ProQR Therapeutics NV | 103.07M |
| Merus NV | 787.42M |
| argenx SE | 3.102B |
| Pharming Group | 160.32M |